[7] In October 2016 the company was valued at £4.4bn in the largest initial public offering on the London Stock Exchange in the year.

[10] On 19 August 2019, Convatec announced Dr John McAdam CBE would become Chairman, effective 30 September, the same day Karim Bitar became CEO.

While many companies ceased or reduced their presence in Russia, ConvaTec continued its business activities there, including the sale of medical products.

In 2023, ConvaTec was included in the "Leave Russia" project, which tracks companies that remain active in the Russian market.

Critics argued that by continuing operations in Russia, ConvaTec indirectly supported the Russian economy and government during the conflict.